BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 11191283)

  • 1. The acid sphingomyelinase inhibitor SR33557 counteracts TNF-alpha-mediated potentiation of IL-1beta-induced NF-kappaB activation in the insulin-producing cell line Rinm5F.
    Saldeen J; Jaffrézou JP; Welsh N
    Autoimmunity; 2000 Dec; 32(4):241-54. PubMed ID: 11191283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of nuclear factor-kappaB activation in cytokine- and sphingomyelinase-stimulated inducible nitric oxide synthase gene expression in vascular smooth muscle cells.
    Katsuyama K; Shichiri M; Marumo F; Hirata Y
    Endocrinology; 1998 Nov; 139(11):4506-12. PubMed ID: 9794459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acidic sphingomyelinase-generated ceramide is needed but not sufficient for TNF-induced apoptosis and nuclear factor-kappa B activation.
    Higuchi M; Singh S; Jaffrezou JP; Aggarwal BB
    J Immunol; 1996 Jul; 157(1):297-304. PubMed ID: 8683130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sphingomyelinase and ceramide stimulate the expression of inducible nitric-oxide synthase in rat primary astrocytes.
    Pahan K; Sheikh FG; Khan M; Namboodiri AM; Singh I
    J Biol Chem; 1998 Jan; 273(5):2591-600. PubMed ID: 9446561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of the mitochondrial antioxidant defense status prevents cytokine-induced nuclear factor-kappaB activation in insulin-producing cells.
    Azevedo-Martins AK; Lortz S; Lenzen S; Curi R; Eizirik DL; Tiedge M
    Diabetes; 2003 Jan; 52(1):93-101. PubMed ID: 12502498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytokine-stimulated inducible nitric oxide synthase expression in astroglia: role of Erk mitogen-activated protein kinase and NF-kappaB.
    Marcus JS; Karackattu SL; Fleegal MA; Sumners C
    Glia; 2003 Jan; 41(2):152-60. PubMed ID: 12509805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation by cytokines of the inducible nitric oxide synthase promoter in insulin-producing cells.
    Darville MI; Eizirik DL
    Diabetologia; 1998 Sep; 41(9):1101-8. PubMed ID: 9754830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid-beta peptide enhances tumor necrosis factor-alpha-induced iNOS through neutral sphingomyelinase/ceramide pathway in oligodendrocytes.
    Zeng C; Lee JT; Chen H; Chen S; Hsu CY; Xu J
    J Neurochem; 2005 Aug; 94(3):703-12. PubMed ID: 16033420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha-induced cyclooxygenase-2 expression via sequential activation of ceramide-dependent mitogen-activated protein kinases, and IkappaB kinase 1/2 in human alveolar epithelial cells.
    Chen CC; Sun YT; Chen JJ; Chang YJ
    Mol Pharmacol; 2001 Mar; 59(3):493-500. PubMed ID: 11179444
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for involvement of the proteasome complex (26S) and NFkappaB in IL-1beta-induced nitric oxide and prostaglandin production by rat islets and RINm5F cells.
    Kwon G; Corbett JA; Hauser S; Hill JR; Turk J; McDaniel ML
    Diabetes; 1998 Apr; 47(4):583-91. PubMed ID: 9568691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid sphingomyelinase-derived ceramide is not required for inflammatory cytokine signalling in murine macrophages.
    Manthey CL; Schuchman EH
    Cytokine; 1998 Sep; 10(9):654-61. PubMed ID: 9770326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine-activated Jak-2 is involved in inducible nitric oxide synthase expression independent from NF-kappaB activation in vascular smooth muscle cells.
    Doi M; Shichiri M; Katsuyama K; Ishimaru S; Hirata Y
    Atherosclerosis; 2002 Jan; 160(1):123-32. PubMed ID: 11755929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory effects of epicatechin on interleukin-1beta-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of NF-kappaB activation.
    Kim MJ; Ryu GR; Kang JH; Sim SS; Min DS; Rhie DJ; Yoon SH; Hahn SJ; Jeong IK; Hong KJ; Kim MS; Jo YH
    Biochem Pharmacol; 2004 Nov; 68(9):1775-85. PubMed ID: 15450943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pyrrolidinone derivative inhibits cytokine-induced iNOS expression and NF-kappaB activation by preventing phosphorylation and degradation of IkappaB-alpha.
    Katsuyama K; Hirata Y
    J Biochem; 2001 Apr; 129(4):585-91. PubMed ID: 11275558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p38 MAPK inhibits JNK2 and mediates cytokine-activated iNOS induction and apoptosis independently of NF-KB translocation in insulin-producing cells.
    Saldeen J; Welsh N
    Eur Cytokine Netw; 2004; 15(1):47-52. PubMed ID: 15217752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acid sphingomyelinase activation requires caspase-8 but not p53 nor reactive oxygen species during Fas-induced apoptosis in human glioma cells.
    Sawada M; Nakashima S; Kiyono T; Yamada J; Hara S; Nakagawa M; Shinoda J; Sakai N
    Exp Cell Res; 2002 Feb; 273(2):157-68. PubMed ID: 11822871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-1 beta-induced ceramide and diacylglycerol generation may lead to activation of the c-Jun NH2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F.
    Welsh N
    J Biol Chem; 1996 Apr; 271(14):8307-12. PubMed ID: 8626526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of inducible nitric oxide synthase in proinflammatory cytokine-stimulated human primary astrocytes.
    Jana M; Anderson JA; Saha RN; Liu X; Pahan K
    Free Radic Biol Med; 2005 Mar; 38(5):655-64. PubMed ID: 15683721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of tumor necrosis factor-induced cell death in MCF7 by a novel inhibitor of neutral sphingomyelinase.
    Luberto C; Hassler DF; Signorelli P; Okamoto Y; Sawai H; Boros E; Hazen-Martin DJ; Obeid LM; Hannun YA; Smith GK
    J Biol Chem; 2002 Oct; 277(43):41128-39. PubMed ID: 12154098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of a dominant negative inhibitor of NF-kappaB protects MIN6 beta-cells from cytokine-induced apoptosis.
    Baker MS; Chen X; Cao XC; Kaufman DB
    J Surg Res; 2001 May; 97(2):117-22. PubMed ID: 11341786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.